文献速递瓣膜外科

微创与常规缘对缘修复治疗Barlow病双叶脱垂所致重度二尖瓣反流的长期结果比较

Minimally invasive or conventional edge-to-edge repair for severe mitral regurgitation due to bileaflet prolapse in Barlow's disease: does the surgical approach have an impact on the long-term results?
PubMed 文献 · Eur J Cardiothorac Surg · 2017-01-01

本研究比较微创右胸小切口与常规胸骨正中切口缘对缘修复在Barlow病双叶脱垂患者中的长期结果,共纳入104例微创组及等量常规组,采用逆概率治疗加权平衡基线差异。随访中位11.3年,两组心脏死亡、复发MR≥3+及≥2+的累积发生率均无显著差异,微创入路不影响修复效果与长期耐久性。

要点

  • 微创入路不增加Barlow病双叶脱垂缘对缘修复的长期心脏死亡风险。
  • 微创与常规组12年复发MR≥3+及≥2+的累积发生率无显著差异。
  • 手术入路不是心脏死亡、再手术或复发MR的预测因素。

核心结论

  • 微创入路对Barlow病双叶脱垂缘对缘修复的有效性和长期耐久性无负面影响。
  • 长期结果优异,瓣膜性能稳定,无二尖瓣狭窄证据。

研究设计与样本

  • 评估104例Barlow病双叶脱垂接受微创缘对缘修复患者的长期结果。
  • 等量常规胸骨正中切口缘对缘修复患者作为对照组。
  • 采用逆概率治疗加权平衡两组基线显著差异的协变量。

主要发现

  • 无院内死亡,随访完整率99.5%,中位随访11.3年。
  • 12年心脏死亡累积发生率函数(以非心脏死亡为竞争风险)两组无差异(P=0.87)。
  • 12年复发MR≥3+累积发生率函数(以死亡为竞争风险)胸骨组7%、微创组5%(P=0.30)。
  • 12年复发MR≥2+累积发生率胸骨组15%、微创组14%(P=0.63)。
  • 手术入路不是心脏死亡、再手术、复发MR≥3+或≥2+的预测因素。

临床怎么用

  • 在Barlow病双叶脱垂患者中,可选择微创右胸小切口行缘对缘修复,长期效果与常规胸骨入路相当。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate whether the adoption of a right minithoracotomy operative approach had an impact on the long-term results of edge-to-edge (EE) repair compared to conventional sternotomy in patients with Barlow's disease and bileaflet prolapse. METHODS: We assessed the long-term results of 104 patients with Barlow's disease treated with a minimally invasive EE technique. An equal number of patients had a conventional median sternotomy EE repair for the same disease and were used as a control group. The inverse probability of treatment weighting was used to create comparable distributions of the covariates that were significantly different at baseline in the two groups. We performed a comparative analysis of the groups. RESULTS: No hospital deaths were observed. Follow-up was 99.5% complete (median 11.3 years). The cumulative incidence function (CIF) of cardiac death at 12 years, with noncardiac death as a competing risk, showed no difference between the two groups ( P = 0.87). At 12 years, the CIF of recurrent MR ≥ 3+, with death as the competing risk, was 7% in the sternotomy group and 5% in the minimally invasive group ( P = 0.30), and the CIF of recurrence of MR ≥ 2+ was 15 and 14%, respectively ( P = 0.63). The type of surgical approach was not a predictor of cardiac death, reoperation, recurrent MR ≥ 3+ or recurrent MR ≥ 2+. CONCLUSIONS: A minimally invasive approach does not have a negative impact on the effectiveness and long-term durability of the EE repair for bileaflet prolapse in Barlow's disease. Long-term outcomes are excellent, and valvular performance remains stable over time with no evidence of mitral stenosis.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. De Bonis M, Lapenna E, Del Forno B, et al. Minimally invasive or conventional edge-to-edge repair for severe mitral regurgitation due to bileaflet prolapse in Barlow's disease: does the surgical approach have an impact on the long-term results? Eur J Cardiothorac Surg. 2017. PMID: 28407104. doi:10.1093/ejcts/ezx032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。